MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Tetralogic Pharmaceuticals Corp Company Profile (NASDAQ:TLOG)

Consensus Ratings for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $1.00 (232.23% upside)

Analysts' Ratings History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
Show:
DateFirmActionRatingPrice TargetActions
1/7/2016Roth CapitalLower Price TargetBuy$5.00 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Needham & Company LLCLower Price TargetBuy$10.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
2/26/2015Q414($0.39)($0.53)$1.13 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($4.34)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.37)($0.37)($0.37)
Q2 20161($0.21)($0.21)($0.21)
Q3 20161($0.22)($0.22)($0.22)
Q4 20161($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)
Dividend History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/9/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell333,630$0.17$56,717.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell1,415,490$0.18$254,788.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell369,132$0.19$70,135.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/28/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell311,930$0.28$87,340.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Andrew L PecoraDirectorBuy50,000$2.68$134,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2015Andrew L PecoraDirectorBuy50,000$2.40$120,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2015Paul J SchmittDirectorBuy10,000$2.34$23,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2015Pete A MeyersCFOBuy5,000$4.35$21,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2015J Kevin BuchiCEOBuy5,000$4.23$21,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015J Kevin BuchiCEOBuy5,000$5.04$25,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Colin Glenn BegleySVPBuy5,900$6.16$36,344.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014J Kevin BuchiCEOBuy5,000$6.01$30,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Pete A MeyersCFOBuy1,034$4.94$5,107.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014J Kevin BuchiCEOBuy10,000$4.99$49,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Colin Glenn BegleySVPBuy3,100$4.86$15,066.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Lesley RussellCOOBuy20,000$4.90$98,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Colin Glenn BegleySVPBuy2,000$4.85$9,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014J Kevin BuchiCEOBuy10,000$4.82$48,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Andrew L PecoraDirectorBuy20,000$4.53$90,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Peter A MeyersCFOBuy5,000$3.98$19,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014J Kevin BuchiCEOBuy10,000$3.93$39,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Paul J SchmittDirectorBuy20,000$4.10$82,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2013J Kevin BuchiCEOBuy285,714$7.00$1,999,998.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2013James N WoodyDirectorBuy261,427$7.00$1,829,989.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2013Peter A MeyersCFOBuy142,857$7.00$999,999.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2013Ventures Vii Lp HealthcareMajor ShareholderBuy713,463$7.00$4,994,241.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)
DateHeadline
06/29/16 09:32 AMTetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Sellers Covered 10.6% of Their Shorts - Press Telegraph
06/27/16 06:42 PMTetralogic Pharmaceuticals Corp : Biotech Hot This Summer
06/22/16 08:25 AMReview of Analysts Ranking: Neovasc Inc. (NASDAQ:NVCN) , TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Street Updates
06/21/16 08:34 AMRecent Analysts Rating Overview: Pfizer, Inc. (NYSE:PFE) , TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Street Updates
06/20/16 08:14 AMThis Weeks Broker Views For TetraLogic Pharmaceuticals Corporation (TLOG) - Fiscal Standard
06/16/16 11:20 AMTetralogic Pharmaceuticals : Biotechnology Stocks on our Radar -- Array BioPharma, PDL BioPharma, Advaxis, and TetraLogic Pharma
06/15/16 03:06 PMTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/06/16 06:59 PMTwo Movers inside Traders Radar: Anthem, Inc. (NYSE:ANTM) , TetraLogic Pharmaceuticals Corporation (NASDAQ ... - Street Updates
06/03/16 07:31 PMAnalyst Earnings Report: Sanofi (NYSE:SNY), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) - Beacon Chronicle
06/02/16 07:20 PMBroker Analysis: TetraLogic Pharmaceuticals Corporation (TLOG) - Share Trading News - Broker Analysis: TetraLogic Pharmaceuticals Corporation (TLOG)Share Trading NewsThe most recently updated broker views and price targets issued for TetraLogic Pharmaceuticals Corporation (TLOG) are below. 01/07/2016 – Broker: Roth Capital Rating: buy New Target: 1 newcoverage. 05/07/2015 – Broker: Needham & Company Rating: ...
05/31/16 10:19 AMNext Weeks Broker Price Targets For TetraLogic Pharmaceuticals Corporation (TLOG) - Share Trading News - Next Weeks Broker Price Targets For TetraLogic Pharmaceuticals Corporation (TLOG)Share Trading NewsTetraLogic Pharmaceuticals Corporation has a 50 day moving average of 0.26 and a 200 day moving average of 0.63. The stock's market capitalization is 7.42M, it has a 52-week low of 0.09 and a 52-week high of 3.75. The share price of the company (TLOG) ...Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Shorted Shares Increased 17.58% After Market SellingThe Postall 4 news articles »
05/28/16 10:41 AMTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) Closes At $0.32 - RealistInvestor.com - TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) Closes At $0.32RealistInvestor.comThe technical analysis of TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) stock highlights the stock is $0.04 points away +16.25% from its 50-day MA of $0.26. It is $-0.33 or -52.63% away $0.63, the 200-day Moving Average (MA) of stock.and more »
05/27/16 11:46 AMHealthcare Trading Stocks: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , TetraLogic Pharmaceuticals Corporation ... - Is stories - Healthcare Trading Stocks: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) , TetraLogic Pharmaceuticals Corporation ...Is storiesIn most recently trading session on 5/26/2016, TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) dropped -5.88% while traded on 1.74 million shares versus it's an average volume of 954.61 thousand shares. The company recorded the last trade with ...and more »
05/25/16 10:49 AMWhat to Do When Looking for the Best Penny Stocks to Buy - Another stock that has had a strong run-up recently is TetraLogic Pharmaceuticals Corp. (Nasdaq: TLOG). In a 15-day period between mid-April and the end of the month, the stock price rose roughly 184%. In late March, Money Morning noted that TLOG is a ...
05/22/16 09:30 PMAfter Last Week What Do Analysts Think Of TetraLogic Pharmaceuticals Corporation (TLOG) - Share Trading News - After Last Week What Do Analysts Think Of TetraLogic Pharmaceuticals Corporation (TLOG)Share Trading News01/06/2014 – Oppenheimer began new coverage on TetraLogic Pharmaceuticals Corporation giving the company a “outperform” rating. The share price of TetraLogic Pharmaceuticals Corporation (TLOG) was up +0.24% during the last trading session, with a ...
05/21/16 12:30 AMBroker Roundup For TetraLogic Pharmaceuticals Corporation (TLOG) - Share Trading News - Broker Roundup For TetraLogic Pharmaceuticals Corporation (TLOG)Share Trading News01/06/2014 – Oppenheimer began new coverage on TetraLogic Pharmaceuticals Corporation giving the company a “outperform” rating. The share price of TetraLogic Pharmaceuticals Corporation (TLOG) was up +0.12% during the last trading session, with a ...Is it Time to Cash in Profits on TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG)Franklin Independentall 2 news articles »
05/17/16 08:11 PMTetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Short Interest Increased By 10.28% - Wall Street Hints and News - Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Short Interest Increased By 10.28%Wall Street Hints and NewsThe stock of Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) registered an increase of 10.28% in short interest. TLOG's total short interest was 984,000 shares in May as published by FINRA. Its up 10.28% from 892,300 shares, reported previously.
05/14/16 04:12 AMInvestors Reviewing Stocks: Prestige Brand Holdings, Inc. (NYSE:PBH) , TetraLogic Pharmaceuticals Corporation ... - Street Updates - Street UpdatesInvestors Reviewing Stocks: Prestige Brand Holdings, Inc. (NYSE:PBH) , TetraLogic Pharmaceuticals Corporation ...Street UpdatesIn the past trading session, TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) highlighted downward shift of -0.90% or -0.00 points to $0.22. The company traded a volume of 204.14 thousand shares under average volume of 917.86 thousand shares.and more »
05/04/16 12:32 PMTETRALOGIC PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report -
05/03/16 09:51 PMTrending Stock Update: Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) - The Point Review - Trending Stock Update: Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)The Point ReviewShare of Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) traded on 12.36 percent above secure line at 3:11PM EDT in order to take the company's stock at the price of $0.300. At the time of writing the stock exchanged hands 1.45 million shares versus ...Scorching Hot Biotech Stocks Tape: TetraLogic Pharmaceuticals Corporation (TLOG), Rock Creek Pharmaceuticals ...ZergwatchBiotech Stocks Worth a Closer Look: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Arena ...Street RegisterTetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Shorts Decreased by 3.86% After Short CoveringThe Postall 4 news articles »
05/03/16 02:21 AMStocks inside Investors Limelight: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) , TetraLogic Pharmaceuticals ... - Street Updates - Seeking AlphaStocks inside Investors Limelight: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) , TetraLogic Pharmaceuticals ...Street UpdatesTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) moved in red zone with decline of -0.0499 points or -14.0563% to $0.3051. The company has a market worth of $7.42M.Total 951.02 thousand shares were exchanged in last trading session as ...TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) Boasts An Average Rating Of 4.5Markets Dailyall 14 news articles »
04/28/16 03:59 AMAnalyst's Valuable Buzzers: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , TetraLogic Pharmaceuticals ... - Street Updates - Analyst's Valuable Buzzers: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , TetraLogic Pharmaceuticals ...Street UpdatesTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) showed bearish move with loss of -28.163% after exchanging volume of 5.09 million shares in last trading session ended on 4/26/2016. The company recent traded volume was higher than its ...and more »
04/27/16 05:44 AMRecently Changed Price Targets On TetraLogic Pharmaceuticals Corporation (TLOG) - Risers & Fallers - Recently Changed Price Targets On TetraLogic Pharmaceuticals Corporation (TLOG)Risers & Fallers01/06/2014 – Oppenheimer began new coverage on TetraLogic Pharmaceuticals Corporation giving the company a “outperform” rating. The share price of TetraLogic Pharmaceuticals Corporation (TLOG) was down -28.16% during the last trading session, ...
04/26/16 08:36 PMHave a look at Price Moves: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) , Medtronic plc (NYSE:MDT) - Street Updates - Have a look at Price Moves: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) , Medtronic plc (NYSE:MDT)Street UpdatesTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) increased +66.10% or +0.20 points. The company traded volume of 13.39 million shares more than average volume of 809.63 thousand shares. It has the market value of $11.92M and its EPS ratio for ...
04/26/16 08:36 PMStocks Under Review: Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) - News Oracle - Stocks Under Review: Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG)News OracleLast Trade: The Company rose 66.10% and finished at $0.49. The daily volume was measured at 13.35 million shares. The 52-week high of the share price is $5.00 and the 52-week low is $0.09. The company has a market cap of $16.19 million. Its latest ...Today Analyst Opinions: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Community Health Systems, Inc ...WsNews 4investorsStocks Trend Analysis: TetraLogic Pharmaceuticals Corporation (TLOG) Tribune Publishing Company (TPUB ...iStreetWireStock Activity: The ADT Corporation (NYSE:ADT), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG ...Property Mentorall 4 news articles »
04/26/16 08:36 PMHealthcare Stocks to watch: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) , Anavex Life Sciences Corp ... - Is stories - Seeking AlphaHealthcare Stocks to watch: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) , Anavex Life Sciences Corp ...Is storiesTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) increased +66.10% to $0.49 while traded 13.33 million shares on 4/25/2016. The stock price negotiated for value between $0.31 to $0.62 in recent trading session. During the past 52 weeks, the ...Hot Biotech Stocks To Watch Right Now: Anavex Life Sciences Corp. (AVXL), TetraLogic Pharmaceuticals Corporation ...Zergwatchall 18 news articles »
04/26/16 05:25 AMStocks In Queue: Gramercy Property Trust Inc. (GPT), TetraLogic Pharmaceuticals Corporation (TLOG), Norwegian ... - iStreetWire - Stocks In Queue: Gramercy Property Trust Inc. (GPT), TetraLogic Pharmaceuticals Corporation (TLOG), Norwegian ...iStreetWireTetraLogic Pharmaceuticals Corporation (TLOG) gained $0.07 to close the day at a new closing price of $0.29, a 33.48% increase in value from its previous closing price that moved the stock 224.18% above its 52 week low of $0.09. A total of 2.41M shares ...and more »
04/25/16 11:44 AMPenny Stocks To Watch: Four Top Small Cap Stocks on Monday April 25 - [Accesswire] - MIAMI, FL / ACCESSWIRE / April 25, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. TLOG, LPTN, OREX, and BTUUQ have been added to our watch list today. Continue reading to find ...
04/23/16 05:15 AMTetraLogic Pharmaceuticals Corporation (TLOG) Analyst Review - Risers & Fallers - TetraLogic Pharmaceuticals Corporation (TLOG) Analyst ReviewRisers & FallersA number of investment brokers have recently updated their price targets on shares of TetraLogic Pharmaceuticals Corporation (TLOG). According to the latest broker reports outstanding on Friday 22nd of April, 0 analysts have a rating of “strong buy”, ...and more »
04/19/16 05:43 AMWill These Stocks Decline? Hemispherx BioPharma (HEB), Tetralogic Pharmaceuticals Corp (TLOG) - News Oracle - News OracleWill These Stocks Decline? Hemispherx BioPharma (HEB), Tetralogic Pharmaceuticals Corp (TLOG)News OracleHemispherx BioPharma, Inc (NYSEMKT:HEB) surged 2.47% friday and closed at $0.141. The company's market capitalization is at $35.77 Million with an average trading volume of 602,337.00 shares. The total number of Outstanding Shares Held by the ...and more »
04/16/16 09:05 AMHot stocks to watch: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) , Aetna Inc. (NYSE:AET) - Is stories - Is storiesHot stocks to watch: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) , Aetna Inc. (NYSE:AET)Is storiesTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) increased +2.33% to $0.22 while traded 1.94 million shares on 4/15/2016. The stock price negotiated for value between $0.20 to $0.29 in recent trading session. During the past 52 weeks, the stock's ...
04/15/16 08:49 AMHealthcare Sector Companies for Investors: Lpath, Inc. (LPTN), Tetralogic Pharmaceuticals Corp (TLOG) - News Oracle - News OracleHealthcare Sector Companies for Investors: Lpath, Inc. (LPTN), Tetralogic Pharmaceuticals Corp (TLOG)News OracleLpath, Inc. (NASDAQ:LPTN) surged 31.58% yesterday and closed at $0.250. The company's market capitalization is at $8.28 Million with an average trading volume of 228,607.00. The total number of Outstanding Shares Held by the company are 33.14 ...3 Stocks in Focus: Lpath Inc. (LPTN), TetraLogic Pharmaceuticals Corporation (TLOG), DragonWave Inc. (DRWI)iStreetWireall 2 news articles »
04/14/16 09:53 AMNorthland Capital Partners View on the City: Churchill Mining, Connemara Mining and Motif Bio - Shukla, Ph.D. as Vice President, Clinical Operations. Mr. Meyers joins the Company from TetraLogic Pharmaceuticals Corporation (NASDAQ: TLOG) where he was CFO and Treasurer. Prior to his role at TetraLogic, Mr. Meyers spent 18 years in health care ...
04/14/16 09:53 AMMotif Bio PLC (MTFB) - Shukla, Ph.D. as Vice President, Clinical Operations. Mr. Meyers joins the Company from TetraLogic Pharmaceuticals Corporation (NASDAQ: TLOG) where he was CFO and Treasurer. Prior to his role at TetraLogic, Mr. Meyers spent 18 years in health care ...
04/09/16 08:10 AMAnalyst Review: TetraLogic Pharmaceuticals Corporation (TLOG) - Risers & Fallers - Analyst Review: TetraLogic Pharmaceuticals Corporation (TLOG)Risers & FallersA number of investment brokers have recently updated their price targets on shares of TetraLogic Pharmaceuticals Corporation (TLOG). According to the latest broker reports outstanding on Friday 8th of April, 0 analysts have a rating of “strong buy”, 1 ...and more »
04/08/16 08:32 AMUpgrades And Downgrades For TetraLogic Pharmaceuticals Corporation (TLOG) - Risers & Fallers - Upgrades And Downgrades For TetraLogic Pharmaceuticals Corporation (TLOG)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of TetraLogic Pharmaceuticals Corporation (TLOG). The latest broker reports which are currently outstanding on Thursday 7th of April state 0 analysts have a rating of “strong ...and more »
04/07/16 03:07 PMTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers -
04/06/16 10:34 AMAnalyst Rating Update on TetraLogic Pharmaceuticals Corporation (TLOG) - SCSUCollegian - Analyst Rating Update on TetraLogic Pharmaceuticals Corporation (TLOG)SCSUCollegianTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1 by 1 Brokerage Firm. 1 Wall Street Firms have rated the stock as a strong buys.
04/05/16 10:11 AMTetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Shorted Shares Increased By 0.71% - RiversideGazette.com - Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Shorted Shares Increased By 0.71%RiversideGazette.comThe stock of Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) registered an increase of 0.71% in short interest. TLOG's total short interest was 734,800 shares in April as published by FINRA. Its up 0.71% from 729,600 shares, reported previously.
04/04/16 12:11 PMCompany Shares of TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) Sinks -3.32% - SCSUCollegian - Company Shares of TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) Sinks -3.32%SCSUCollegianTetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) has tumbled 3.32% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 0.28% in the last four weeks. The stocks are negative ...TetraLogic Pharmaceuticals Corporation (TLOG) Broker Price Targets For The Coming WeekShare Trading Newsall 2 news articles »
03/31/16 10:03 PMTetraLogic Pharmaceuticals Corporation (TLOG) Updated Broker Ratings - Risers & Fallers - TetraLogic Pharmaceuticals Corporation (TLOG) Updated Broker RatingsRisers & FallersA number of investment brokers have recently updated their price targets on shares of TetraLogic Pharmaceuticals Corporation (TLOG). According to the latest broker reports outstanding on Thursday 31st of March, 0 analysts have a rating of “strong buy”, ...Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Shorted Shares Increased 0.71% After Market SellingBusiness Standard Tribuneall 2 news articles »
03/31/16 11:14 AMTetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Shorted Shares Increased 0.71% After Market Selling - Business Standard Tribune - Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) Shorted Shares Increased 0.71% After Market SellingBusiness Standard TribuneThe stock of Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) registered an increase of 0.71% in short interest. TLOG's total short interest was 734,800 shares in March as published by FINRA. Its up 0.71% from 729,600 shares, reported previously.New Broker Ratings For TetraLogic Pharmaceuticals Corporation (TLOG)FTSE Newsall 2 news articles »
03/22/16 12:04 PMTETRALOGIC PHARMACEUTICALS CORP Financials -
02/26/16 06:01 AMTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rul -
02/03/16 12:49 PMThese Biotech Companies are Helping Turn Around the Sector for Major Gains in 2016 - [Accesswire] - LAS VEGAS, NV / ACCESSWIRE / February 3, 2016 / The most notable of the pack is Propanc Health Group Corporation ( PPCH ) , which is an exciting, young company within the sector. Propanc, whose focus is ...
01/29/16 05:04 AMTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Regulation FD Disclosure -
01/22/16 07:11 AMTETRALOGIC PHARMACEUTICALS CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Dire -
01/07/16 10:12 AMTetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs - [at noodls] - Birinapant Shows No Activity in Randomized Phase 2 MDS Study SHAPE Shows Clinical Benefit in Randomized Phase 2 CTCL Study TetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG), a clinical-stage biopharmaceutical ...
01/07/16 07:41 AMHere's Why Tetralogic Pharmaceuticals Is Down 70% -
12/31/15 09:02 AMLifeSci Capital Initiates Coverage of TetraLogic Pharmaceuticals Corporation - [Accesswire] - Developing therapies for Oncology and Infectious Diseases; Report Available here: http://www.lifescicapital.com/equity-research/tetralogic/ NEW YORK, NY / ACCESSWIRE / December 31, 2015 / LifeSci Capital, ...
About Tetralogic Pharmaceuticals Corp

Tetralogic Pharmaceuticals Corp logoTetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TLOG
  • CUSIP:
Key Metrics:
  • Previous Close: $0.30
  • 50 Day Moving Average: $0.301
  • 200 Day Moving Average: $0.389
  • P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $7.32M
  • Current Quarter EPS Consensus Estimate: $-1.770 EPS
Additional Links:
Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha